Drugs and Devices

FDA approves new drug for type 2 diabetes

On August 1, the U.S. Food and Drug Administration (FDA) approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve glycemic control in adults with type 2 diabetes. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares